TABLE 1.

Percentage of ASV integration events into RefSeq genes: comparison with HIV-1 and MLV studies^a

Virus	Total no. of integrations	Cell type	% Integration into RefSeq genesb
			N02	J03
ASV	226	HeLa	39.8e	42.0e
HIV-1c	524	SupT1	61.0	(71.7)
HIV-1d	379	H9/HeLa	57.8f	(67.9)
HIV-1d	135	HeLa	50.0	(58.8)
MLVd	903	HeLa	34.2g	(40.2)
Randomd	10,000	Simulated	22.4	(26.3)

^aResults from the present study are shown in boldface.

^bN02, November 2002 assembly of RefSeq genes (18,214 genes); J03, July 2003 assembly of RefSeq genes (21,404 genes). Values in parentheses indicate extrapolated proportional increase in RefSeq targets by using the July 2003 assembly versus the November 2002 assembly used by Wu et al. (43).

^cRaw data are from the work of Schröder et al. (34) and were reevaluated by Wu et al. (43) using RefSeq genes. Values were compared with ASV by using the 2 × 2 chi-square test with the Yates correction (P ≤ 1.3 × 10⁻⁷).

^dFrom the work of Wu et al. (43).

^eValues are significantly different from random integration (P ≤ 2.13 × 10⁻⁷) with the 2 × 2 chi-square test with the Yates correction.

^fValue was reported to be significantly different from random integration (43).

^gValue was reported to be significantly different from random integration and HIV-1 value of 57.8 (43). Value is indistinguishable from ASV value (39.8) (P = 0.134), by the 2 × 2 chi-square test with the Yates correction.